China Resources Pharmaceutical: Jiangzhong Pharmaceutical's first-quarter revenue is approximately RMB 1.227 billion, a year-on-year decrease of 8.74%
I'm PortAI, I can summarize articles.
According to the Zhitong Finance APP, CR Pharma has announced the performance of Jiangzhong Pharmaceutical in the first quarter of 2024, with total operating income of approximately 1.227 billion RMB, a year-on-year decrease of 8.74%; net profit is around 285 million RMB, a year-on-year increase of 9.55%
Log in to access the full 0 words article for free
Due to copyright restrictions, please log in to view.
Thank you for supporting legitimate content.
Source: Zhitong The copyright of this article belongs to the original author/organization.
The views expressed herein are solely those of the author and do not reflect the stance of the platform. The content is intended for investment reference purposes only and shall not be considered as investment advice. Please contact us if you have any questions or suggestions regarding the content services provided by the platform.
Post your comment
No Comments